We are live on ! Find out more
CPAH

Counterpath Corp
CPAH

Delisted

CPAH was delisted on the 26th of February, 2021.

0 hedge funds and large institutions have $0 invested in Counterpath Corp in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 60 (-6)

100% less capital invested

Capital invested by funds: $2.33M → $0 (-$2.33M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
Holders Change
-6
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BCM
1
Beryl Capital Management
California
-$1.09M -320,423 Closed
Renaissance Technologies
2
Renaissance Technologies
New York
-$915K -269,196 Closed
BCM
3
Bridgeway Capital Management
Texas
-$321K -94,000 Closed
UBS Group
4
UBS Group
Switzerland
-$1K -366 Closed

CPAH Hedge Fund Activity: Q1 2021 in Review

0 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Counterpath Corp (CPAH) for Q1 2021, worth a combined $0 — down 100% from $2.33M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of CPAH and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Beryl Capital Management, exiting entirely with an estimated $1.09M sold.

  • 0 institutional investors held Counterpath Corp (CPAH) as of Q1 2021, down from 6 in Q4 2020.
  • Funds reported $0 of Counterpath Corp stock for Q1 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Counterpath Corp positions in Q1 2021 and 6 closed out, a net change of -6 holders.
  • The largest Counterpath Corp seller in Q1 2021 was Beryl Capital Management, an estimated $1.09M sold.

Based on aggregated 13F filings for Q1 2021.